Ganluyin ameliorates DSS-induced ulcerative colitis by inhibiting the enteric-origin LPS/TLR4/NF-κB pathway
Bibliographic Data
Biology · Blot · Colitis · Disease · Epithelium · Goblet cell · Inflammation · Intestinal mucosa · Lipopolysaccharide · Mucus · NF-κB · Occludin · Pathology · Tight junction · TLR4 · Ulcerative colitis · Gut microbiota and health · Inflammatory Bowel Disease · Medicine · Mycobacterium research and diagnosis · Biochemistry · Immunology · Internal Medicine
Multi-Omics-Driven Network Pharmacology and Experimental Validation Reveal the Molecular Mechanism of Bupi Yichang Pill in Treating Ulcerative Colitis Through Regulation of the PI3K/Akt/IKK/NF-κB Pathway
Exploring the efficacy and mechanism of Bailing capsule to improve polycystic ovary syndrome in mice based on intestinal-derived LPS-TLR4 pathway
Crude Polygalae Radix after boiling with licorice decoction alleviates intestinal mucosal barrier injury of rats by regulating TLR4/NF-κB signaling pathway
Shuang-Xin-Tong-Tiao formula from Menghe medicine exerts dual cardioprotective and antidepressant effects associated with the suppression of Toll-like receptor 4 / nuclear factor kappa-B / hypoxia-inducible factor-1 alpha signaling
Notoginsenoside R1 interferes with PGAM5-NEK7 interaction to inhibit NLRP3 inflammasome activation in macrophages and ameliorate DSS-induced colitis
The aqueous extract of Reynoutria japonica ameliorates damp-heat ulcerative colitis in mice by modulating gut microbiota and metabolism
The total alkaloids of Berberidis Cortex alleviate type 2 diabetes mellitus by regulating gut microbiota, inflammation and liver gluconeogenesis
Study on anti-inflammatory effect of Shangkehuangshui in vitro and in vivo based on TLR4/TLR2-NF-κB signaling pathway
Honokiol targeting ankyrin repeat domain of TRPV4 ameliorates endothelial permeability in mice inflammatory bowel disease induced by DSS
Traditional Chinese Medicine formulas-based interventions on colorectal carcinoma prevention
Cantharidin-induced enterotoxicity
| Unique citing works | 11 |
|---|---|
| Citations per year | 5,5 |
| Citation span | 2024 - 2026 (3) |
| Citation velocity | current |
| Highly cited | No |
| Citation types | Neutral: 10 |